GENEVA, April 22 (Bernama-dpa) -- Swiss pharmaceutical giant Roche on Tuesday said it will invest US$50 billion in the United States in the next five years, German news agency (dpa) reported.
The commitment includes new state-of-the art research and development sites as well as new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California.
The investments are expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities.
“Roche is a Swiss company with a strong heritage in more than 130 countries globally. Today’s announced investments underscore our long-standing commitment to research, development and manufacturing in the US,” said chief executive Thomas Schinecker.
The company noted that the added capacity will allow it to export more medicines from the US than it imports.
-- BERNAMA-dpa
